DE60100364T2 - Wasserlösliche pharmazeutische Darreichungsform, ausgenommen Brause-Formen, welche nicht-steroidale antientzündliche Wirkstoffe enthält - Google Patents

Wasserlösliche pharmazeutische Darreichungsform, ausgenommen Brause-Formen, welche nicht-steroidale antientzündliche Wirkstoffe enthält

Info

Publication number
DE60100364T2
DE60100364T2 DE60100364T DE60100364T DE60100364T2 DE 60100364 T2 DE60100364 T2 DE 60100364T2 DE 60100364 T DE60100364 T DE 60100364T DE 60100364 T DE60100364 T DE 60100364T DE 60100364 T2 DE60100364 T2 DE 60100364T2
Authority
DE
Germany
Prior art keywords
water
except
dosage form
active ingredients
pharmaceutical dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60100364T
Other languages
English (en)
Other versions
DE60100364D1 (de
Inventor
Alberto Reiner
Giorgio Reiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
APR Applied Pharma Research SA
Original Assignee
APR Applied Pharma Research SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by APR Applied Pharma Research SA filed Critical APR Applied Pharma Research SA
Application granted granted Critical
Publication of DE60100364D1 publication Critical patent/DE60100364D1/de
Publication of DE60100364T2 publication Critical patent/DE60100364T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60100364T 2001-11-20 2001-11-20 Wasserlösliche pharmazeutische Darreichungsform, ausgenommen Brause-Formen, welche nicht-steroidale antientzündliche Wirkstoffe enthält Expired - Lifetime DE60100364T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01204432A EP1312355B1 (de) 2001-11-20 2001-11-20 Wasserlösliche pharmazeutische Darreichungsform, ausgenommen Brause-Formen, welche nicht-steroidale antientzündliche Wirkstoffe enthält

Publications (2)

Publication Number Publication Date
DE60100364D1 DE60100364D1 (de) 2003-07-31
DE60100364T2 true DE60100364T2 (de) 2003-12-04

Family

ID=8181265

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60100364T Expired - Lifetime DE60100364T2 (de) 2001-11-20 2001-11-20 Wasserlösliche pharmazeutische Darreichungsform, ausgenommen Brause-Formen, welche nicht-steroidale antientzündliche Wirkstoffe enthält

Country Status (9)

Country Link
EP (1) EP1312355B1 (de)
AT (1) ATE242626T1 (de)
AU (1) AU2002356685A1 (de)
BR (1) BR0206371A (de)
DE (1) DE60100364T2 (de)
DK (1) DK1312355T3 (de)
ES (1) ES2199916T3 (de)
PT (1) PT1312355E (de)
WO (1) WO2003043600A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100567131B1 (ko) * 2004-01-05 2006-04-05 신일제약주식회사 쓴맛을 차폐한 아르기닌 함유 이부프로펜 경구투여 액상조성물
FR2865648B1 (fr) 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
US7776318B2 (en) 2004-11-26 2010-08-17 L'oreal S.A. Liquid cleaning composition comprising at least one anionic surfactant and its use for cleansing human keratin materials
JO3352B1 (ar) * 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
WO2013022410A2 (en) 2011-08-08 2013-02-14 Mahmut Bilgic Production method for effervescent formulations comprising dexketoprofen
EP3508199A1 (de) * 2018-01-05 2019-07-10 Dompé farmaceutici S.p.A. Schnell freisetzende pharmazeutische zusammensetzungen mit ketoprofen-lysinsalz
US11260026B2 (en) 2018-12-14 2022-03-01 Apr Applied Pharma Research Sa Ready to use diclofenac stick packs
KR20230022941A (ko) 2020-06-10 2023-02-16 에이피알 어플라이드 파르마 리서어치 에스.에이. 생체이용성 당-기반 디클로페낙 제형

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8920693D0 (en) * 1989-09-13 1989-10-25 Nicholas Kiwi Pty Ltd Non-effervescent ibuprofen compositions
DE4403943A1 (de) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat

Also Published As

Publication number Publication date
PT1312355E (pt) 2003-10-31
AU2002356685A1 (en) 2003-06-10
BR0206371A (pt) 2003-12-23
EP1312355B1 (de) 2003-06-11
WO2003043600A1 (en) 2003-05-30
EP1312355A1 (de) 2003-05-21
ATE242626T1 (de) 2003-06-15
ES2199916T3 (es) 2004-03-01
DE60100364D1 (de) 2003-07-31
DK1312355T3 (da) 2003-10-06

Similar Documents

Publication Publication Date Title
DK1341524T3 (da) Farmaceutisk præparat i form af en pasta omfattende en syre-labil aktiv bestanddel
EP1444984B1 (de) Topische pharmazeutische Zusammensetzungen enthaltend aktive natürliche Bestandteile zur Verhütung und Behandlung von mucosalen Entzündungprozessen
AU2002330645B2 (en) Composition comprising paracetamol and a bitterness masking component
JP2014208652A (ja) 発泡性組成物
ATE455539T1 (de) Darreichungsformen mit verlängerter wirkstofffreisetzung
DE60100364D1 (de) Wasserlösliche pharmazeutische Darreichungsform, ausgenommen Brause-Formen, welche nicht-steroidale antientzündliche Wirkstoffe enthält
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
AU733083B2 (en) Pharmaceutical compositions based on diclofenac
JPH01246221A (ja) フエノール含有鎮咳液体組成物
EP3236938B1 (de) Orale topische wässrige pharmazeutische zusammensetzungen aus flurbiprofen und dexpanthenol
JP2006347958A (ja) 咽頭粘膜抗炎症スプレー剤
CA2547194C (en) Pharmaceutical oral dosage form comprising a non-steroidal anti-inflammatory drug, and having good palatability
CA2429793A1 (en) Interferon therapeutic effect enhancer
GB2327041A (en) Topical Analgesic Composition
WO2016116909A2 (en) Non-staining topical gel compositions of nimesulide
JP4084329B2 (ja) 液状組成物およびその製造方法
AR015531A1 (es) Composicion farmaceutica oral, concentrado farmaceutico y proceso para prepararlo
WO2014027976A1 (en) Topical aqueous pharmaceutical compositions of flurbiprofen and chlorhexidine
JP2023147254A (ja) 口内炎発症抑制組成物
BG61892B2 (bg) Състав на основата на ибупрофен за орална употреба
BRPI0403668B8 (pt) composições farmacêuticas de desintegração oral com altas concentrações de aspartame

Legal Events

Date Code Title Description
8364 No opposition during term of opposition